LambdaVision Advances Space-Based Manufacturing With Its First Mission Beyond the ISS

WOODBRIDGE, Conn.--(BUSINESS WIRE)--LambdaVision, a pre-clinical-stage biotech advancing on-Earth and microgravity bioprocesses, today announced an upcoming mission with Helogen Corporation to deepen its knowledge of the space-based properties of the protein used in LambdaVision’s artificial retina. Scheduled to launch in October 2026, the mission will mark LambdaVision’s first flight beyond the International Space Station (ISS) and an essential next step in the company’s strategy to expand its